Blood polyphenol concentrations and differentiated thyroid carcinoma in women from the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
EPIC
biomarkers
nested case–control study
polyphenol
thyroid cancer
Journal
The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027
Informations de publication
Date de publication:
04 Jan 2021
04 Jan 2021
Historique:
received:
26
03
2020
accepted:
07
09
2020
pubmed:
7
10
2020
medline:
7
10
2020
entrez:
6
10
2020
Statut:
ppublish
Résumé
Polyphenols are natural compounds with anticarcinogenic properties in cellular and animal models, but epidemiological evidence determining the associations of these compounds with thyroid cancer (TC) is lacking. The aim of this study was to evaluate the relations between blood concentrations of 36 polyphenols and TC risk in EPIC (the European Prospective Investigation into Cancer and Nutrition). A nested case-control study was conducted on 273 female cases (210 papillary, 45 follicular, and 18 not otherwise specified TC tumors) and 512 strictly matched controls. Blood polyphenol concentrations were analyzed by HPLC coupled to tandem MS after enzymatic hydrolysis. Using multivariable-adjusted conditional logistic regression models, caffeic acid (ORlog2: 0.55; 95% CI: 0.33, 0.93) and its dehydrogenated metabolite, 3,4-dihydroxyphenylpropionic acid (ORlog2: 0.84; 95% CI: 0.71, 0.99), were inversely associated with differentiated TC risk. Similar results were observed for papillary TC, but not for follicular TC. Ferulic acid was also inversely associated only with papillary TC (ORlog2: 0.68; 95% CI: 0.51, 0.91). However, none of these relations was significant after Bonferroni correction for multiple testing. No association was observed for any of the remaining polyphenols with total differentiated, papillary, or follicular TC. Blood polyphenol concentrations were mostly not associated with differentiated TC risk in women, although our study raises the possibility that high blood concentrations of caffeic, 3,4-dihydroxyphenylpropionic, and ferulic acids may be related to a lower papillary TC risk.
Sections du résumé
BACKGROUND
BACKGROUND
Polyphenols are natural compounds with anticarcinogenic properties in cellular and animal models, but epidemiological evidence determining the associations of these compounds with thyroid cancer (TC) is lacking.
OBJECTIVES
OBJECTIVE
The aim of this study was to evaluate the relations between blood concentrations of 36 polyphenols and TC risk in EPIC (the European Prospective Investigation into Cancer and Nutrition).
METHODS
METHODS
A nested case-control study was conducted on 273 female cases (210 papillary, 45 follicular, and 18 not otherwise specified TC tumors) and 512 strictly matched controls. Blood polyphenol concentrations were analyzed by HPLC coupled to tandem MS after enzymatic hydrolysis.
RESULTS
RESULTS
Using multivariable-adjusted conditional logistic regression models, caffeic acid (ORlog2: 0.55; 95% CI: 0.33, 0.93) and its dehydrogenated metabolite, 3,4-dihydroxyphenylpropionic acid (ORlog2: 0.84; 95% CI: 0.71, 0.99), were inversely associated with differentiated TC risk. Similar results were observed for papillary TC, but not for follicular TC. Ferulic acid was also inversely associated only with papillary TC (ORlog2: 0.68; 95% CI: 0.51, 0.91). However, none of these relations was significant after Bonferroni correction for multiple testing. No association was observed for any of the remaining polyphenols with total differentiated, papillary, or follicular TC.
CONCLUSIONS
CONCLUSIONS
Blood polyphenol concentrations were mostly not associated with differentiated TC risk in women, although our study raises the possibility that high blood concentrations of caffeic, 3,4-dihydroxyphenylpropionic, and ferulic acids may be related to a lower papillary TC risk.
Identifiants
pubmed: 33021645
pii: S0002-9165(22)00569-X
doi: 10.1093/ajcn/nqaa277
pmc: PMC7779226
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
162-171Subventions
Organisme : Medical Research Council
ID : MC_UU_00006/1
Pays : United Kingdom
Organisme : Regional Governments of Andalucía
Organisme : Medical Research Council
ID : MC_UU_12015/1
Pays : United Kingdom
Organisme : Dutch Prevention Funds
Organisme : Netherlands National Institute for Public Health and the Environment
Organisme : European Regional Development Fund
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : German Cancer Aid
Organisme : Swedish Research Council
Organisme : Hellenic Health Foundation
Organisme : Swedish Cancer Society
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Organisme : Ligue Contre le Cancer
Organisme : International Agency for Research on Cancer
Organisme : Netherlands Cancer Registry
Organisme : Medical Research Council
ID : 1000143
Pays : United Kingdom
Organisme : Statistics Netherlands
Organisme : Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy
Organisme : Dutch Ministry of Health, Welfare and Sport
Organisme : Federal Ministry of Education and Research
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Institut National de la Santé et de la Recherche Médicale
Organisme : LK Research Funds
Organisme : Danish Cancer Society
Organisme : Instituto de Salud Carlos III
ID : CP15/00100
Organisme : European Commission (DG-SANCO)
Organisme : German Cancer Research Center
Organisme : World Cancer Research Fund
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : National Research Council
Organisme : Catalan Institute of Oncology-ICO
Organisme : Ministry of Education and Research
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : County Councils of Skåne and Västerbotten
Organisme : Health Research Fund
Organisme : Institut Gustave Roussy
Organisme : Mutuelle Générale de l'Education Nationale
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the American Society for Nutrition.